Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.

Investlytic score: 2/5 criteria met. Data as of 03/10/2026.
- ✅ Price trend passed
- ⚠️ Mixed growth
- ❌ Debt failed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): the price has been multiplied by at least 1.5.
Price change 2018 → 2019: 24.14%
Price change 2019 → 2020: -7.89%
Price change 2020 → 2021: 33.10%
Price change 2021 → 2022: 15.81%
Price change 2022 → 2023: -8.62%
Price change 2023 → 2024: 23.82%
Price change 2024 → 2025: -3.59%
Price change 2025 → 2026: 19.52%
Price change 2026 (year to date): 17.47%
Financial growth
Revenue CAGR (8 years): 1.82%
Earnings CAGR (8 years): -5.77%
Growth status: positive trend (>1%/yr) in revenue OR earnings, but not both.
Debt
Debt-to-equity ratio: 0.71
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 9.67
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 5.60% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="MET" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| MetLife, Inc. | 10.1 | 0.71 | +2.6 % | 🔒 |
| Aflac Incorporated | 16.4 | 0.28 | −1.1 % | – |
| Deutsche Börse AG | 25.7 | 0.72 | +9.1 % | – |
| The Allstate Corporation | 5.7 | 0.24 | +5.1 % | ★ 4/5 |
| Nasdaq, Inc. | 29.4 | 0.81 | +6.5 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by MetLife, Inc. over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2020 | 67.9 bn | 5.4 bn | 8.0 % | n/a |
| 2021 | 63.4 bn | 6.9 bn | 10.8 % | -6.7 % |
| 2022 | 68.0 bn | 5.3 bn | 7.8 % | +7.3 % |
| 2023 | 67.7 bn | 1.6 bn | 2.3 % | -0.4 % |
| 2024 | 69.9 bn | 4.4 bn | 6.3 % | +3.3 % |
| 2025 | 77.1 bn | 3.4 bn | 4.4 % | +10.2 % |
Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.
Accounts and financial health
Balance sheet and cash flow published by MetLife, Inc. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash and investments | 367 bn | 313 bn | 317 bn | 109 bn | 125 bn |
| Total Debt | 17.4 bn | 18.0 bn | 18.8 bn | 18.7 bn | 20.2 bn |
| Net Debt | -2.6 bn | -2.2 bn | -1.8 bn | -1.4 bn | -1.8 bn |
| Equity | 67.5 bn | 29.9 bn | 30.0 bn | 27.4 bn | 28.4 bn |
| Total assets | 760 bn | 663 bn | 688 bn | 677 bn | 745 bn |
| Operating cash flow | 12.8 bn | 11.4 bn | 14.3 bn | 15.1 bn | 18.1 bn |
| Investments (capex) | -4.4 bn | 0 | 1.2 bn | 0 | 0 |
| Free cash-flow | 12.8 bn | 11.4 bn | 14.3 bn | 15.1 bn | 18.1 bn |
| Share buybacks | 4.8 bn | 3.3 bn | 3.1 bn | 3.2 bn | 3.9 bn |
| Dividends paid | 1.6 bn | 1.6 bn | 1.6 bn | 1.5 bn | 1.5 bn |
Amounts in USD, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.
Valuation and competitors
MetLife, Inc. compared with its sector on the same exchange and with its main competitors.
Direct competitors
| Company | Market cap (USD) | P/E | Net margin |
|---|---|---|---|
| MetLife, Inc. | 62.4 bn | 10.1 | 4.4 % |
| Prudential Financial, Inc. PRU | 41.1 bn | 7.8 | 5.9 % |
| Lincoln National Corporation LNC | 7.7 bn | 4.8 | 6.5 % |
| Manulife Financial Corporation MFC | 71.7 bn | 13.5 | 10.9 % |
| Aflac Incorporated AFL | 62.2 bn | 16.4 | 20.9 % |
| Voya Financial, Inc. VOYA | 9.0 bn | 12.1 | 8.7 % |
| Unum Group UNM | 12.2 bn | 9.3 | 5.7 % |
| Globe Life Inc. GL | 12.1 bn | 10.6 | 19.4 % |
| Primerica, Inc. PRI | 8.9 bn | 11.7 | 23.3 % |
| Sector median (NYSE) | 18.7 |
Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 13/11/2026. Competitors: comparable companies named by the data provider.
Analyst consensus and forecasts
What the financial analysts covering MetLife, Inc. publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Average target over the last 3 months: 110.25 USD (8 targets).
Analyst forecasts
| Fiscal year | Revenue | Net income | Expected EPS (range) | P/E on this EPS | Analysts |
|---|---|---|---|---|---|
| 2026 | 79.4 bn | 6.6 bn | 10.24 (7.41 / 10.77) | 9.6 | 11 |
| 2027 | 83.3 bn | 6.8 bn | 11.16 (7.58 / 12.07) | 8.8 | 11 |
| 2028 | 87.1 bn | 8.2 bn | 12.44 (10.87 / 13.68) | 7.9 | 7 |
Amounts in USD, the reporting currency.
Track record against expectations: reported EPS above consensus 7 times over the last 12 releases.
Rating changes (12 months)
| Date | Firm | Before | After |
|---|---|---|---|
| 12/11/2026 | Wells Fargo | Overweight | Overweight |
| 12/11/2026 | Mizuho | Outperform | Outperform |
| 09/11/2026 | Piper Sandler | Overweight | Overweight |
| 21/10/2026 | TD Cowen | Buy | Buy |
| 15/10/2026 | JP Morgan | Overweight | Overweight |
Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.
Dividends and earnings
MetLife, Inc.: dividend history, last distributions, stock splits and earnings releases.
Annual dividend per share (USD), adjusted for splits. Light bar: current year, incomplete. Red bar: lower than the previous year.
Latest ex-dividend dates
| Ex-dividend | Amount | Payment |
|---|---|---|
| 03/11/2026 | 0.593 USD | 08/12/2026 |
| 04/08/2026 | 0.593 USD | 08/09/2026 |
| 12/05/2026 | 0.593 USD | 09/06/2026 |
| 03/02/2026 | 0.568 USD | 10/03/2026 |
| 04/11/2025 | 0.568 USD | 09/12/2025 |
| 05/08/2025 | 0.568 USD | 09/09/2025 |
| 06/05/2025 | 0.568 USD | 10/06/2025 |
| 04/02/2025 | 0.545 USD | 11/03/2025 |
Earnings releases
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 04/11/2026 | 2.78 | 2.77 | +0.4 % |
| 05/08/2026 | 2.43 | 2.30 | +5.7 % |
| 06/05/2026 | 2.42 | 2.27 | +6.6 % |
| 04/02/2026 | 2.58 | 2.34 | +10.3 % |
| 05/11/2025 | 2.34 | 2.31 | +1.3 % |
| 06/08/2025 | 2.02 | 2.15 | -6.0 % |
Stock splits
| Date | Operation |
|---|---|
| 07/08/2017 | split: 561 shares for 500 |
Factual data: ex-dividend history and earnings calendar, as of 15/11/2026. A past dividend does not guarantee the next one.
Who owns the stock
Free float, institutional investors, large funds, executives and elected officials: declared positions in MetLife, Inc.
Indices: S&P 500 (since 11/12/2000).
Large funds tracked
| Fund | Shares | Value (USD) | Weight in the fund | Change | Quarter |
|---|---|---|---|---|---|
| Vanguard Group | 72.6 m | 5.7 bn | 0.1 % | +12.1 % | 2025Q4 |
| BlackRock | 51.8 m | 4.4 bn | 0.1 % | +0.7 % | 2026Q2 |
| State Street | 50.7 m | 4.3 bn | 0.1 % | +100.9 % | 2026Q2 |
| Dodge & Cox | 48.4 m | 4.1 bn | 2.1 % | -5.3 % | 2026Q2 |
| T. Rowe Price | 21.3 m | 1.8 bn | 0.2 % | -6.6 % | 2026Q2 |
| Geode Capital Management | 13.3 m | 1.1 bn | 0.1 % | +0.5 % | 2026Q2 |
| Morgan Stanley | 12.5 m | 1.1 bn | 0.1 % | +12.7 % | 2026Q2 |
| Invesco | 6.9 m | 586 m | 0.1 % | +0.2 % | 2026Q2 |
Latest insider transactions
| Date | Person | Side | Amount |
|---|---|---|---|
| 10/11/2026 | Khalaf Michel | sale | 19.3 m USD |
Elected officials' disclosures
| Date | Official | Side | Amount |
|---|---|---|---|
| 27/03/2026 | Alan Armstrong | purchase | $1,001 - $15,000 |
| 02/06/2026 | Ro Khanna | purchase | $1,001 - $15,000 |
| 29/01/2026 | Ro Khanna | sale | $15,001 - $50,000 |
| 13/01/2026 | Ro Khanna | purchase | $1,001 - $15,000 |
Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 16/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about MetLife, Inc.
What is the MetLife, Inc. share price?
Latest recorded price: 102.65 USD on 13/11/2026, for a market cap of 64.5 bn USD.
What is the revenue of MetLife, Inc.?
77.1 bn USD for fiscal year 2025, with net income of 3.4 bn USD (net margin 4.4 %).
Does MetLife, Inc. pay a dividend?
Yes. Latest dividend: 0.593 USD per share, ex-dividend on 03/11/2026. Over 12 months: 2.35 USD. Yield on the latest known price: 3.2 %.
When does MetLife, Inc. report its next earnings?
The next release is expected on 03/02/2027. EPS expected by analysts: 2.62.
What do analysts say about MetLife, Inc.?
Out of 33 analysts: 26 buy or strong buy, 7 hold, 0 sell or strong sell. Average price target: 108.78 USD, i.e. +10.7 % from the share price.
What is the P/E ratio of MetLife, Inc.?
Trailing 12-month P/E of 10.5, against 18.7 for the sector median on the same exchange (10-year median: 18.5).
Is MetLife, Inc. stock eligible for the French PEA?
No: the company is headquartered outside the European Union and the European Economic Area (ISIN US59156R1086).
How many employees does MetLife, Inc. have?
45,000 full-time employees according to the latest published profile.
Who runs MetLife, Inc.?
Michel Abbas Khalaf is the company's chief executive.
Which large funds own MetLife, Inc.?
As of 2026Q2, among the large funds tracked: Vanguard Group, BlackRock, State Street, Dodge & Cox, T. Rowe Price.